Clinical observation of GEM+NVB regimen in retreatment of 24 Advanced NSCLC treated by TAX+DDP regimen
- VernacularTitle:吉西他滨联合长春瑞滨方案复治对紫杉醇联合顺铂方案疗效欠佳的晚期非小细胞肺癌24例临床观察
- Author:
Tong ZHANG
;
Guoping REN
;
Zhenhai ZHANG
- Publication Type:Journal Article
- Keywords:
non-small-cell lung cancer;
GEM;
NVB;
TAX;
DDP
- From:
Cancer Research and Clinic
2000;0(01):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To appraise the efficacy,survival rate and toxicity of GEM+NVB regimen in retreatment of 24 Advanced NSCLC treated by TAX+DDP regimen.Methods 24 patients with Advanced NSCLC received chemotherapy of GEM+NVB regimen.We evaluate the efficacy,survival rate and toxicity after two periods.Results Among these 24 patients,there was no complete response.Rates of partial response is 29.2 %,the average survival period is 28 weeks.One year survival rate is 34.3 %.Conclusions GEM+NVB regimen is effective as second-line chemotherapy for the Advanced NSCLC patients that have ever been treaded by TAX+DDP regimen.
